Lung tumor cells and tumor-infiltrating antigen-presenting cells express PD-L1, which, by interacting with PD-1 on T cells, can inactivate the effector functions of both CD4+ Th1 T cells and CD8+ CTLs, leading to the evasion of antitumor immune responses [21, 22]. The gene discussed is PDCD1; the disease is neoplasm.